16-1614824-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_020825.4(CRAMP1):c.185C>T(p.Pro62Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000244 in 1,271,112 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_020825.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CRAMP1 | NM_020825.4 | c.185C>T | p.Pro62Leu | missense_variant | 2/21 | ENST00000397412.8 | NP_065876.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CRAMP1 | ENST00000397412.8 | c.185C>T | p.Pro62Leu | missense_variant | 2/21 | 5 | NM_020825.4 | ENSP00000380559.2 | ||
CRAMP1 | ENST00000293925.9 | c.185C>T | p.Pro62Leu | missense_variant | 1/20 | 5 | ENSP00000293925.5 | |||
CRAMP1 | ENST00000674071.1 | c.*26C>T | downstream_gene_variant | ENSP00000501151.1 |
Frequencies
GnomAD3 genomes AF: 0.0000198 AC: 3AN: 151700Hom.: 0 Cov.: 31
GnomAD4 exome AF: 0.0000250 AC: 28AN: 1119412Hom.: 0 Cov.: 29 AF XY: 0.0000223 AC XY: 12AN XY: 538338
GnomAD4 genome AF: 0.0000198 AC: 3AN: 151700Hom.: 0 Cov.: 31 AF XY: 0.0000270 AC XY: 2AN XY: 74080
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 21, 2023 | The c.185C>T (p.P62L) alteration is located in exon 1 (coding exon 1) of the CRAMP1 gene. This alteration results from a C to T substitution at nucleotide position 185, causing the proline (P) at amino acid position 62 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at